HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Salvage therapy for patients with lymphoma.

Abstract
Although the majority of patients with lymphoma achieve a complete remission with primary therapy, two thirds or more will fail to achieve an initial remission or will eventually relapse from complete remission and require salvage therapy. The response to salvage therapy will depend on a number of factors, including type of lymphoma (Hodgkin's v non-Hodgkin's), stage of disease, type of salvage therapy, prior therapy, number of relapses, and duration of initial remission. In general, the likelihood of attaining a complete remission is greatest with primary therapy and declines with each relapse. Therefore, it is tremendously important that patients with lymphoma be managed optimally at the time of their initial treatment.
AuthorsJ O Armitage, J M Vose, P J Bierman, M R Bishop
JournalSeminars in oncology (Semin Oncol) Vol. 21 Issue 4 Suppl 7 Pg. 82-5 (Aug 1994) ISSN: 0093-7754 [Print] United States
PMID8091246 (Publication Type: Journal Article, Review)
Topics
  • Bone Marrow Transplantation
  • Humans
  • Lymphoma (drug therapy, radiotherapy, therapy)
  • Salvage Therapy
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: